Zhen Lü

10.6k total citations
160 papers, 4.8k citations indexed

About

Zhen Lü is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Zhen Lü has authored 160 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 34 papers in Oncology and 31 papers in Epidemiology. Recurrent topics in Zhen Lü's work include Autophagy in Disease and Therapy (26 papers), Ovarian cancer diagnosis and treatment (21 papers) and Epigenetics and DNA Methylation (18 papers). Zhen Lü is often cited by papers focused on Autophagy in Disease and Therapy (26 papers), Ovarian cancer diagnosis and treatment (21 papers) and Epigenetics and DNA Methylation (18 papers). Zhen Lü collaborates with scholars based in United States, China and United Kingdom. Zhen Lü's co-authors include Robert C. Bast, Douglas Cyr, Yinhua Yu, Warren S.‐L. Liao, Karen H. Lu, Donna Badgwell, Robert Z. Luo, Steven J. Skates, Weiqun Mao and Hailing Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Zhen Lü

152 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhen Lü United States 40 2.9k 1.0k 963 785 730 160 4.8k
Rebecca T. Marquez United States 24 1.8k 0.6× 867 0.9× 481 0.5× 564 0.7× 417 0.6× 32 3.1k
Mirco Ponzoni Italy 44 3.4k 1.2× 1.1k 1.1× 1.2k 1.2× 353 0.4× 258 0.4× 174 5.9k
Tao Yi China 36 1.9k 0.7× 831 0.8× 673 0.7× 316 0.4× 274 0.4× 206 4.1k
Bülent Özpolat United States 45 4.3k 1.5× 1.7k 1.7× 904 0.9× 170 0.2× 931 1.3× 147 6.4k
Alfonso Calvo Spain 40 2.4k 0.8× 1.0k 1.0× 1.5k 1.6× 248 0.3× 230 0.3× 198 5.0k
Stanley Lipkowitz United States 38 4.2k 1.5× 1.1k 1.0× 2.4k 2.5× 249 0.3× 308 0.4× 109 6.3k
Hee Gu Lee South Korea 37 2.0k 0.7× 522 0.5× 729 0.8× 144 0.2× 454 0.6× 140 3.8k
Shengtao Zhou China 30 1.4k 0.5× 771 0.8× 516 0.5× 309 0.4× 239 0.3× 97 2.7k
Marta Mendiola Spain 30 1.8k 0.6× 685 0.7× 937 1.0× 166 0.2× 211 0.3× 95 3.3k
Matthias Nees Finland 35 2.3k 0.8× 882 0.9× 1.1k 1.1× 97 0.1× 522 0.7× 78 4.1k

Countries citing papers authored by Zhen Lü

Since Specialization
Citations

This map shows the geographic impact of Zhen Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Lü more than expected).

Fields of papers citing papers by Zhen Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Lü. The network helps show where Zhen Lü may publish in the future.

Co-authorship network of co-authors of Zhen Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Lü. A scholar is included among the top collaborators of Zhen Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Lü. Zhen Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jianxin, Xiaolang Liu, Shu-Hao Yao, et al.. (2024). All-purpose additive anchoring interface enables formation of stable uniform electrolyte-anode interphase for high performance aqueous Zn metal batteries. Chemical Engineering Journal. 503. 158342–158342. 2 indexed citations
2.
Zhang, Xudong, et al.. (2024). Crizotinib Enhances PARP Inhibitor Efficacy in Ovarian Cancer Cells and Xenograft Models by Inducing Autophagy. Molecular Cancer Research. 22(9). 840–851. 4 indexed citations
3.
Lü, Zhen, Qian Lai, Li Z, et al.. (2024). Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic Leukemia. Current Medical Science. 44(2). 298–308. 3 indexed citations
4.
Zhao, Rui, et al.. (2024). Enhancement of ammonia corrosion resistance of coatings through improving dispersion and binding site of graphene oxide in silane coatings. Journal of Alloys and Compounds. 989. 174174–174174. 5 indexed citations
5.
Lü, Zhen, et al.. (2024). Potential analysis of a perovskite solar cell-thermally regenerative electrochemical cycles/refrigerators hybrid system. Applied Thermal Engineering. 250. 123539–123539. 1 indexed citations
6.
Bărăgău, Ioan-Alexandru, et al.. (2024). Maximizing polypropylene recovery from waste carpet feedstock: a solvent-driven pathway towards circular economy. RSC Sustainability. 2(5). 1367–1371. 1 indexed citations
7.
Xiang, Jingjing, Zhen Lü, Qiaoyun Zhu, et al.. (2023). Study on the corrosion inhibition performance of composite inhibitor on carbon steel in stone processing wastewater. Asia-Pacific Journal of Chemical Engineering. 19(1). 6 indexed citations
8.
Lü, Zhen, et al.. (2023). Focusing and rotating magnetic nanoparticle clusters for fast ablation of thrombus. Journal of Materials Science. 58(19). 8022–8033. 1 indexed citations
9.
Irajizad, Ehsan, Chae Young Han, Joseph Celestino, et al.. (2022). A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses. Clinical Cancer Research. 28(21). 4669–4676. 10 indexed citations
10.
Gray, Joshua P., Rajan Chaudhari, Margie N. Sutton, et al.. (2021). Directed evolution of cyclic peptides for inhibition of autophagy. Chemical Science. 12(10). 3526–3543. 27 indexed citations
11.
Kobayashi, Makoto, Hiroyuki Katayama, Ehsan Irajizad, et al.. (2020). Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis. Cancers. 12(2). 485–485. 7 indexed citations
12.
Lü, Zhen, Jing Guo, Bryan Fellman, et al.. (2019). Human epididymis protein 4 antigen‐autoantibody complexes complement cancer antigen 125 for detecting early‐stage ovarian cancer. Cancer. 126(4). 725–736. 23 indexed citations
13.
Yang, Hailing, Weiqun Mao, Cristian Rodriguez‐Aguayo, et al.. (2018). Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability. Clinical Cancer Research. 24(20). 5072–5084. 32 indexed citations
14.
Yang, Wei-Lei, Aleksandra Gentry‐Maharaj, Andy Ryan, et al.. (2017). Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer. Clinical Cancer Research. 23(19). 5912–5922. 44 indexed citations
15.
Li, Qian, et al.. (2017). Softening Hard Stool Using Magnetically Controlled Fe3O4 Nanoparticles. Sensors and Materials. 1749–1749. 1 indexed citations
16.
Zhou, Jinhua, Shu Zhang, Abdulkhaliq Alsaadi, et al.. (2016). A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel. Clinical Cancer Research. 23(8). 1945–1954. 48 indexed citations
17.
Zhang, Shu, Zhen Lü, Anna K. Unruh, et al.. (2014). Clinically Relevant microRNAs in Ovarian Cancer. Molecular Cancer Research. 13(3). 393–401. 70 indexed citations
18.
Ahmed, Ahmed A., Xiaoyan Wang, Zhen Lü, et al.. (2011). Modulating Microtubule Stability Enhances the Cytotoxic Response of Cancer Cells to Paclitaxel. Cancer Research. 71(17). 5806–5817. 45 indexed citations
19.
Xie, Xiaoming, Jennifer L. Hsu, Min Gew Choi, et al.. (2009). A novel hTERT promoter–driven E1A therapeutic for ovarian cancer. Molecular Cancer Therapeutics. 8(8). 2375–2382. 30 indexed citations
20.
Luo, Robert Z., Zhen Lü, Shilpi Khare, et al.. (2005). Expression of the tumor suppressor gene ARHI induces autophagic cell death in ovarian cancer cells. Cancer Research. 65. 199–199. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026